Drug Calms Overly Excitable Brains in Autism Rodent Models

Published February 10, 2014 in Simons Foundation Autism Research Initiative

The blood pressure drug bumetanide normalizes a deficit in brain activity in two rodent models of autism, according to a study published in Science. The study hints at a mechanism underlying the drugs benefits for people with autism. Neurochlore, a company based in Marseilles, France, is testing bumetanide as a treatment for autism. In the first phase, 27 children with autism showed some improvement in their autism symptoms; the researchers are continuing the trial in Europe with more participants.


Filed under: , , , ,